These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 34888241)
1. Defining the Spectrum, Treatment and Outcome of Patients With Genetically Confirmed Gorlin Syndrome From the HIT-MED Cohort. Kloth K; Obrecht D; Sturm D; Pietsch T; Warmuth-Metz M; Bison B; Mynarek M; Rutkowski S Front Oncol; 2021; 11():756025. PubMed ID: 34888241 [TBL] [Abstract][Full Text] [Related]
2. Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort. Mynarek M; von Hoff K; Pietsch T; Ottensmeier H; Warmuth-Metz M; Bison B; Pfister S; Korshunov A; Sharma T; Jaeger N; Ryzhova M; Zheludkova O; Golanov A; Rushing EJ; Hasselblatt M; Koch A; Schüller U; von Deimling A; Sahm F; Sill M; Riemenschneider MJ; Dohmen H; Monoranu CM; Sommer C; Staszewski O; Mawrin C; Schittenhelm J; Brück W; Filipski K; Hartmann C; Meinhardt M; Pietschmann K; Haberler C; Slavc I; Gerber NU; Grotzer M; Benesch M; Schlegel PG; Deinlein F; von Bueren AO; Friedrich C; Juhnke BO; Obrecht D; Fleischhack G; Kwiecien R; Faldum A; Kortmann RD; Kool M; Rutkowski S J Clin Oncol; 2020 Jun; 38(18):2028-2040. PubMed ID: 32330099 [TBL] [Abstract][Full Text] [Related]
3. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations. Smith MJ; Beetz C; Williams SG; Bhaskar SS; O'Sullivan J; Anderson B; Daly SB; Urquhart JE; Bholah Z; Oudit D; Cheesman E; Kelsey A; McCabe MG; Newman WG; Evans DG J Clin Oncol; 2014 Dec; 32(36):4155-61. PubMed ID: 25403219 [TBL] [Abstract][Full Text] [Related]
4. Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups. Tonn S; Korshunov A; Obrecht D; Sill M; Spohn M; von Hoff K; Milde T; Pietsch T; Goschzik T; Bison B; Juhnke BO; Struve N; Sturm D; Sahm F; Bockmayr M; Friedrich C; von Bueren AO; Gerber NU; Benesch M; Jones DTW; Kool M; Wefers AK; Schüller U; Pfister SM; Rutkowski S; Mynarek M Neuro Oncol; 2023 Aug; 25(8):1518-1529. PubMed ID: 36715306 [TBL] [Abstract][Full Text] [Related]
5. Differences in RNA and microRNA Expression Between PTCH1- and SUFU-mutated Medulloblastoma. Gershanov S; Toledano H; Pernicone N; Fichman S; Michowiz S; Pinhasov A; Goldenberg-Cohen N; Listovsky T; Salmon-Divon M Cancer Genomics Proteomics; 2021; 18(3):335-347. PubMed ID: 33893086 [TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of medulloblastomas with extensive nodularity (MBEN). Korshunov A; Sahm F; Stichel D; Schrimpf D; Ryzhova M; Zheludkova O; Golanov A; Lichter P; Jones DTW; von Deimling A; Pfister SM; Kool M Acta Neuropathol; 2018 Aug; 136(2):303-313. PubMed ID: 29569031 [TBL] [Abstract][Full Text] [Related]
7. Medulloblastoma and other neoplasms in patients with heterozygous germline SUFU variants: A scoping review. Lee SG; Evans G; Stephen M; Goren R; Bondy M; Goodman S Am J Med Genet A; 2024 Jun; 194(6):e63496. PubMed ID: 38282294 [TBL] [Abstract][Full Text] [Related]
8. Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts. Mynarek M; Obrecht D; Sill M; Sturm D; Kloth-Stachnau K; Selt F; Ecker J; von Hoff K; Juhnke BO; Goschzik T; Pietsch T; Bockmayr M; Kool M; von Deimling A; Witt O; Schüller U; Benesch M; Gerber NU; Sahm F; Jones DTW; Korshunov A; Pfister SM; Rutkowski S; Milde T Acta Neuropathol; 2023 Jan; 145(1):97-112. PubMed ID: 36459208 [TBL] [Abstract][Full Text] [Related]
9. [Identification of a Family with SUFU Germline Deletion Based on a Case of Desmoplastic Medulloblastoma in an Infant]. Šoukalová J; Vejmělková K; Cermanová T; Kašíková K; Mikulášová A; Janyšková H; Melichárková K; Pavelka Z; Ježová M; Pospíšilová Š; Kuglík P; Valášková I; Gaillyová R; Štěrba J; Zitterbart K Klin Onkol; 2016; 29 Suppl 1():S83-8. PubMed ID: 26691947 [TBL] [Abstract][Full Text] [Related]
10. SHH desmoplastic/nodular medulloblastoma and Gorlin syndrome in the setting of Down syndrome: case report, molecular profiling, and review of the literature. Mangum R; Varga E; Boué DR; Capper D; Benesch M; Leonard J; Osorio DS; Pierson CR; Zumberge N; Sahm F; Schrimpf D; Pfister SM; Finlay JL Childs Nerv Syst; 2016 Dec; 32(12):2439-2446. PubMed ID: 27444290 [TBL] [Abstract][Full Text] [Related]
11. Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis. Guerrini-Rousseau L; Dufour C; Varlet P; Masliah-Planchon J; Bourdeaut F; Guillaud-Bataille M; Abbas R; Bertozzi AI; Fouyssac F; Huybrechts S; Puget S; Bressac-De Paillerets B; Caron O; Sevenet N; Dimaria M; Villebasse S; Delattre O; Valteau-Couanet D; Grill J; Brugières L Neuro Oncol; 2018 Jul; 20(8):1122-1132. PubMed ID: 29186568 [TBL] [Abstract][Full Text] [Related]
12. High frequency of germline SUFU mutations in children with desmoplastic/nodular medulloblastoma younger than 3 years of age. Brugières L; Remenieras A; Pierron G; Varlet P; Forget S; Byrde V; Bombled J; Puget S; Caron O; Dufour C; Delattre O; Bressac-de Paillerets B; Grill J J Clin Oncol; 2012 Jun; 30(17):2087-93. PubMed ID: 22508808 [TBL] [Abstract][Full Text] [Related]
13. Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221). Lafay-Cousin L; Bouffet E; Strother D; Rudneva V; Hawkins C; Eberhart C; Horbinski C; Heier L; Souweidane M; Williams-Hughes C; Onar-Thomas A; Billups CA; Fouladi M; Northcott P; Robinson G; Gajjar A J Clin Oncol; 2020 Jan; 38(3):223-231. PubMed ID: 31774708 [TBL] [Abstract][Full Text] [Related]
14. Congenital medulloblastoma in two brothers with SUFU-mutated Gorlin-Goltz syndrome: Case reports and literature review. Chen Y; Zhang H; Zhao Y; Ma J Front Oncol; 2022; 12():988798. PubMed ID: 36313636 [TBL] [Abstract][Full Text] [Related]
15. Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG). Guerrini-Rousseau L; Smith MJ; Kratz CP; Doergeloh B; Hirsch S; Hopman SMJ; Jorgensen M; Kuhlen M; Michaeli O; Milde T; Ridola V; Russo A; Salvador H; Waespe N; Claret B; Brugieres L; Evans DG Fam Cancer; 2021 Oct; 20(4):317-325. PubMed ID: 33860896 [TBL] [Abstract][Full Text] [Related]
16. Mutations in SUFU and PTCH1 genes may cause different cutaneous cancer predisposition syndromes: similar, but not the same. Huq AJ; Walsh M; Rajagopalan B; Finlay M; Trainer AH; Bonnet F; Sevenet N; Winship IM Fam Cancer; 2018 Oct; 17(4):601-606. PubMed ID: 29356994 [TBL] [Abstract][Full Text] [Related]
17. First evidence of genotype-phenotype correlations in Gorlin syndrome. Evans DG; Oudit D; Smith MJ; Rutkowski D; Allan E; Newman WG; Lear JT J Med Genet; 2017 Aug; 54(8):530-536. PubMed ID: 28596197 [TBL] [Abstract][Full Text] [Related]
18. Clinical, pathological, and molecular data on desmoplastic/nodular medulloblastoma: case studies and a review of the literature. Siegfried A; Bertozzi AI; Bourdeaut F; Sevely A; Loukh N; Grison C; Miquel C; Lafon D; Sevenet N; Pietsch T; Dufour C; Delisle MB Clin Neuropathol; 2016; 35(3):106-13. PubMed ID: 26857864 [TBL] [Abstract][Full Text] [Related]
19. An intrathecal limited postoperative chemotherapy regimen for the treatment of young children with nodular/desmoplastic medulloblastoma and medulloblastoma with extensive nodularity. Naung H; Cohen KJ J Neurooncol; 2021 May; 152(3):567-572. PubMed ID: 33689104 [TBL] [Abstract][Full Text] [Related]